WHO Drug Information Vol. 13, No. 4, 1999
(1999; 83 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoGeneral Policy Issues
Abrir esta carpeta y ver su contenidoReports on Individual Drugs
Abrir esta carpeta y ver su contenidoCurrent Topics
Abrir esta carpeta y ver su contenidoVaccines and Biomedicines
Cerrar esta carpetaRegulatory and Safety Matters
Ver el documentoLeflunomide: pancytopenia and skin reactions
Ver el documentoDidanosine and pancreatitis
Ver el documentoSertraline for post-traumatic stress disorder
Ver el documentoPemoline withdrawal following liver complications
Ver el documentoLevetiracetam: new drug for epilepsy
Ver el documentoMethotrexate: monitoring essential
Ver el documentoMethotrexate: care in prescribing
Ver el documentoGrepafloxacin withdrawal: severe cardiovascular events
Ver el documentoReteplase incompatible with heparin
Ver el documentoPostmarketing system to be revised
Ver el documentoAbacavir: hypersensitivity reactions
Ver el documentoInitiative to curb illegal sale of drugs over the Internet
Ver el documentoUnapproved HIV test kits available on the Internet
Ver el documentoV-King®: unapproved use of sildenafil
Ver el documentoMiralex®: undeclared corticosteroid
Ver el documentoRules for dietary supplements finalized
Abrir esta carpeta y ver su contenidoATC/DDD Classification
Abrir esta carpeta y ver su contenidoEssential Drugs
Ver el documentoInternational Nonproprietary Names for Pharmaceutical Substances (INN)
Ver el documentoSelected WHO Publications of Related Interest
 

V-King®: unapproved use of sildenafil

Canada — Health Canada is warning consumers not to use V-King (Extra)® capsules. Promoted as natural health products, they may contain sildenafil citrate, a prescription-only drug approved for male erectile dysfunction. Inappropriate use of sildenafil can cause severe adverse reactions and the drug should not be used by persons taking nitrate-containing products concurrently since this could result in the development of potentially life-threatening low blood pressure.

The labelling indicates the ingredients as Harp seal reproductive organ extracts, traditional Chinese herbs, and supplements. V-King® has not been assessed by Health Canada, which attributes an eight-digit drug identification number on licensing.

Reference: Health Canada warning dated 20 January 2000. http://www.hc-sc.gc.ca

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013